Patent classifications
C07F5/06
Spiky metal organic framework, method for fabricating thereof, and kit for treating cancer
A spiky metal organic framework is provided in the present disclosure. The spiky metal organic framework is formed by a coordination reaction between at least one metal ion and an organic ligand, and includes a body and a plurality of spike-like structures. The body is a spherical shape, and a particle size of the body is 1 μm to 3 μm. The spike-like structures are distributed on a surface of the body, a diameter of each spike-like structure is 15 nm to 35 nm, and a length of each spike-like structure is 250 nm to 400 nm.
PROCESS FOR PREPARING DIALKYL ALUMINUM ALKOXIDES
Provided is a robust process for preparing dialkylaluminum alkoxides from trialkyl aluminum species and aluminum alkoxides, performed in a non-coordinating solvent. In certain embodiments, the reaction can be facilitated by the use of at least one static mixer.
ORGANO-ALUMINUM ANALYTES FOR NONAQUEOUS REDOX FLOW BATTERIES
The present disclosure features materials and methods for electrical energy storage. For example, organometallic complexes for use as NRFB analytes, including an organometallic salt represented by formula IV wherein M is a Group 13 metal, Ph is phenyl, Ar is 2-methoxyphenyl, and X is a large counter-ion, NRFBs and electrical energy storage systems comprising the organometallic salt are provided.
##STR00001##
A POLYESTER MOLDING COMPRISING A METAL-ORGANIC FRAMEWORK HAVING A LOW OUTGASSING OF VOLATILE ORGANIC COMPOUNDS
The present invention relates to a molding comprising, (i) a polyester in an amount in the range of from 25 to 99.99 weight-%, based on the total weight of the molding, (ii) a metal-organic framework in an amount of from 0.01 to 25 weight-%, based on the total weight of the molding, wherein the metal-organic framework comprises one or more metal ions M and one or more organic ligands. Further, the present invention relates to a process for preparation of such a molding and use thereof.
ALUMINUM PRECURSOR, METHOD OF FORMING A THIN LAYER USING THE SAME, METHOD OF MANUFACTURING THE SAME, AND METHOD OF MANUFACTURING MEMORY DEVICE
Disclosed is a method for manufacturing an aluminum precursor formed by mixing 1 to 3 moles of a compound represented by the following Chemical Formula 1 or following Chemical Formula 2 and 1 to 3 moles of a compound represented by the following Chemical Formula 3.
##STR00001##
wherein X is O or S, and R1 or R2 is each independently selected from an alkyl group having 1 to 8 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, and an aryl group having 6 to 12 carbon atoms.
##STR00002##
wherein X is O or S, n is 1 to 5, and R1 to R4 are each independently selected from a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, and an aryl group having 6 to 12 carbon atoms.
##STR00003##
wherein R1, R2 and R3 are different from each other, and each independently selected from a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a dialkylamine having 1 to 6 carbon atoms, a cycloamine group having 1 to 6 carbon atoms, or a halogen atom.
TUMOR STROMA IMAGING AGENT AND PREPARATION METHOD THEREOF
A tumor stroma imaging agent with a chemical structural formula (I):
##STR00001##
is provided, where R is hydrogen or fluorine. Compared with the prior art, the tumor stroma imaging agent exhibits significant affinity for fibroblast activation protein (FAP), high uptake for a malignant tumor with high FAP expression in a tumor stroma, and high sensitivity and specificity for the diagnosis of a malignant tumor, and is not prone to false positives. Therefore, the tumor stroma imaging agent can be effectively and safely used for the diagnosis and treatment of various malignant tumors with a prolonged half-life and an extended window period, which is conducive to clinical application.
Process for the generation of metal-containing films
A process including bringing a solid substrate in contact with a compound of general formula (I), (II), (III), or (IV) in the gaseous state ##STR00001##
where A is NR.sub.2 or OR with R being an alkyl group, an alkenyl group, an aryl group, or a silyl group,
E is NR or O,
n is 0, 1 or 2, m is 0, 1 or 2, and
R′ is hydrogen, an alkyl group, an alkenyl group, an aryl group, or a silyl group.
ORGANOMETALLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME
An organometallic compound represented by Formula 1, which is explained in the specification, is provided. A light-emitting device is provided, which includes a first electrode, a second electrode facing the first electrode, an interlayer between the first electrode and the second electrode and including an emission layer, and the organometallic compound. An electronic apparatus including the light-emitting device is also provided:
##STR00001##
Polyolefin-based polymer nanocomposite containing zinc oxide particles and method of producing same
A method for producing aluminum oxide is provided. The method uses an aluminum-oxide-forming agent containing a partially hydrolyzed aluminum alkyl compound containing an aluminum trialkyl or a mixture thereof, and a solvent. It is thus possible to produce an aluminum oxide thin film or aluminum oxide particles on or in a substrate that is not resistant to polar solvents. A method of producing a polyolefin-based polymer nanocomposite containing zinc oxide particles or aluminum oxide particles using a solution containing a partially hydrolyzed zinc alkyl or a solution containing a partially hydrolyzed aluminum alkyl is also provided. The polyolefin-based polymer nanocomposite contains a polyolefin substrate and zinc oxide particles or aluminum oxide particles, and does not contain a dispersant. The zinc oxide particles or aluminum oxide particles have an average particle size of less than 100 nm.
Magnesium salts
A salt of the formula: Mg[Al(R).sub.4].sub.2, where R represents a halogen-free compound selected from a deprotonated alcohol or thiol; or an amine; or a mixture thereof.